Kelli B. Pointer

1.5k total citations
30 papers, 975 citations indexed

About

Kelli B. Pointer is a scholar working on Oncology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kelli B. Pointer has authored 30 papers receiving a total of 975 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 8 papers in Genetics and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kelli B. Pointer's work include Glioma Diagnosis and Treatment (8 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Lung Cancer Diagnosis and Treatment (5 papers). Kelli B. Pointer is often cited by papers focused on Glioma Diagnosis and Treatment (8 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Lung Cancer Diagnosis and Treatment (5 papers). Kelli B. Pointer collaborates with scholars based in United States, Singapore and United Kingdom. Kelli B. Pointer's co-authors include John S. Kuo, Paul A. Clark, Sean P. Pitroda, Ralph R. Weichselbaum, Kevin W. Eliceiri, Sergiy Libert, Leonard Guarente, M. Shahriar Salamat, Wen Zhu and Dandan Sun and has published in prestigious journals such as Cell, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Kelli B. Pointer

27 papers receiving 962 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kelli B. Pointer United States	13	309	295	135	133	125	30	975
Alonso Barrantes‐Freer Germany	16	120 0.4×	448 1.5×	163 1.2×	109 0.8×	64 0.5×	32	1.2k
Luca Tiberi Italy	17	248 0.8×	857 2.9×	29 0.2×	118 0.9×	76 0.6×	28	1.2k
Barbara Mania‐Farnell United States	18	118 0.4×	698 2.4×	31 0.2×	107 0.8×	94 0.8×	37	1.1k
Francesca Casagrande Italy	19	224 0.7×	326 1.1×	88 0.7×	51 0.4×	31 0.2×	29	905
Terence Burns United States	6	134 0.4×	192 0.7×	88 0.7×	83 0.6×	157 1.3×	9	668
Sarah Seton-Rogers United States	13	329 1.1×	603 2.0×	91 0.7×	253 1.9×	56 0.4×	199	1.0k
Devin Chandler-Militello United States	16	197 0.6×	1.3k 4.4×	47 0.3×	226 1.7×	116 0.9×	22	1.9k
Francisco Sánchez‐Sánchez Spain	22	236 0.8×	842 2.9×	98 0.7×	169 1.3×	27 0.2×	55	1.6k
Mitsukuni Yoshida United States	9	254 0.8×	974 3.3×	42 0.3×	551 4.1×	212 1.7×	14	1.8k

Countries citing papers authored by Kelli B. Pointer

Since Specialization

Citations

This map shows the geographic impact of Kelli B. Pointer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelli B. Pointer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelli B. Pointer more than expected).

Fields of papers citing papers by Kelli B. Pointer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelli B. Pointer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelli B. Pointer. The network helps show where Kelli B. Pointer may publish in the future.

Co-authorship network of co-authors of Kelli B. Pointer

This figure shows the co-authorship network connecting the top 25 collaborators of Kelli B. Pointer. A scholar is included among the top collaborators of Kelli B. Pointer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelli B. Pointer. Kelli B. Pointer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Diallo, Alos, Gokul Raghavendra Srinivasan, Kelli B. Pointer, et al.. (2025). Feasibility of Inferring Spatial Transcriptomics from Single-Cell Histological Patterns for Studying Colon Cancer Tumor Heterogeneity. 444–458.

Spurr, Liam F., Carlos Alberto Martínez, Woojin Kang, et al.. (2023). Concurrent Radiation and Immunotherapy Augments Local Immunity and Improves Survival in Aneuploid NSCLC. International Journal of Radiation Oncology*Biology*Physics. 117(2). S23–S23. 1 indexed citations

Levy, Joshua, Mustafa Nasir-Moin, Fred Kolling, et al.. (2023). Identification of Spatial Proteomic Signatures of Colon Tumor Metastasis. American Journal Of Pathology. 193(6). 778–795. 11 indexed citations

Germino, Elizabeth, Anjali L. Saripalli, Kekoa Taparra, et al.. (2023). Tailored Mentorship for the Underrepresented and Allies in Radiation Oncology: The Association of Residents in Radiation Oncology Equity and Inclusion Subcommittee Mentorship Experience. International Journal of Radiation Oncology*Biology*Physics. 116(2). 368–374. 4 indexed citations

Bestvina, Christine M., Kelli B. Pointer, Sean P. Pitroda, et al.. (2023). OA22.03 The Addition of Multisite SBRT to Ipilimumab and Nivolumab in First Line Metastatic NSCLC: The COSINR Trial. Journal of Thoracic Oncology. 18(11). S95–S96. 2 indexed citations

Drifka, Cole R., Kelli B. Pointer, Yuming Liu, et al.. (2021). Navigating the Collagen Jungle: The Biomedical Potential of Fiber Organization in Cancer. Bioengineering. 8(2). 17–17. 62 indexed citations

Bestvina, Christine M., Kelli B. Pointer, Theodore Karrison, et al.. (2021). A Phase 1 Trial of Concurrent or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients With Stage IV NSCLC Study. Journal of Thoracic Oncology. 17(1). 130–140. 77 indexed citations

Juloori, Aditya, Christine M. Bestvina, Sean P. Pitroda, et al.. (2021). RO01.01 Prospective Evaluation of Ipilimumab and Nivolumab in Patients with Non-Small Cell Lung Cancer Brain Metastasis. Journal of Thoracic Oncology. 16(1). S45–S45. 1 indexed citations

Pointer, Kelli B., Sean P. Pitroda, & Ralph R. Weichselbaum. (2021). Radiotherapy and immunotherapy: open questions and future strategies. Trends in cancer. 8(1). 9–20. 103 indexed citations

10.

Patel, Jyoti D., Christine M. Bestvina, Theodore Karrison, et al.. (2020). Randomized phase I trial to evaluate Concurrent or Sequential Ipilimumab, Nivolumab, and stereotactic body Radiotherapy in patients with stage IV non-small cell lung cancer (COSINR Study).. Journal of Clinical Oncology. 38(15_suppl). 9616–9616. 10 indexed citations

11.

Pointer, Kelli B., Jeffrey V. Brower, Matthew E. Witek, et al.. (2017). Small cell carcinoma of the head and neck: An analysis of the National Cancer Database. Oral Oncology. 69. 92–98. 49 indexed citations

12.

Pointer, Kelli B., Paul A. Clark, Kevin W. Eliceiri, et al.. (2016). Administration of Non-Torsadogenic human Ether-à-go-go-Related Gene Inhibitors Is Associated with Better Survival for High hERG–Expressing Glioblastoma Patients. Clinical Cancer Research. 23(1). 73–80. 38 indexed citations

13.

Pointer, Kelli B., et al.. (2016). Association of collagen architecture with glioblastoma patient survival. Journal of neurosurgery. 126(6). 1812–1821. 88 indexed citations

14.

Zhang, Ray R., Kelli B. Pointer, & John S. Kuo. (2015). New Molecular Insights and Potential Therapies for Diffuse Intrinsic Pontine Glioma. Neurosurgery. 77(4). N13–N14. 1 indexed citations

15.

Zhu, Wen, Gulnaz Begum, Kelli B. Pointer, et al.. (2014). WNK1-OSR1 kinase-mediated phospho-activation of Na+-K+-2Cl- cotransporter facilitates glioma migration. Molecular Cancer. 13(1). 31–31. 76 indexed citations

16.

Pointer, Kelli B., Paul A. Clark, Michael Zorniak, Bahauddeen M. Alrfaei, & John S. Kuo. (2014). Glioblastoma cancer stem cells: Biomarker and therapeutic advances. Neurochemistry International. 71. 1–7. 64 indexed citations

17.

Zhang, Ray R., Kelli B. Pointer, John S. Kuo, & Robert J. Dempsey. (2014). Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma. Neurosurgery. 75(6). N9–N10. 27 indexed citations

18.

Zhu, Wen, Yejie Shi, Kelli B. Pointer, et al.. (2014). Upregulation of NHE1 protein expression enables glioblastoma cells to escape TMZ-mediated toxicity via increased H⁺extrusion, cell migration and survival. Carcinogenesis. 35(9). 2014–2024. 70 indexed citations

19.

Libert, Sergiy, Michael S. Bonkowski, Kelli B. Pointer, Scott D. Pletcher, & Leonard Guarente. (2012). Deviation of innate circadian period from 24 h reduces longevity in mice. Aging Cell. 11(5). 794–800. 56 indexed citations

20.

Libert, Sergiy, Kelli B. Pointer, Eric L. Bell, et al.. (2011). SIRT1 Activates MAO-A in the Brain to Mediate Anxiety and Exploratory Drive. Cell. 147(7). 1459–1472. 196 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact